embed embed2
  • Cordlife Philippines Launches Affordable Umbilical Cord Banking Services

    Umbilical cord banking shows greater promise in future therapeutic applications.
  • mom and baby in hospital

    Cordlife Philippines, the leading cord blood and tissue banking service provider in the country, continues its commitment to innovation with the launch of its newest service: umbilical cord banking. The offering allows expectant parents to store their newborn’s umbilical cord -- and the stem cells it contains -- for potential use in future therapeutic applications.

    “The introduction of umbilical cord banking represents the latest milestone for Cordlife Philippines, one which reflects our dedication to introducing pioneering products and services to our customers,” said Jeremy Yee, Executive Director and Chief Executive Officer of Cordlife Group Limited. “We take great pride in offering Filipino parents the additional option of storing their child’s cord tissue to help them further safeguard their family’s future.”

    Banking on cells
    According to Dr. Arvin Faundo, Medical Director of Cordlife Philippines, the umbilical cord is abundant with two types of stem cells: epithelial stem cells (EpSCs) and mesenchymal stem cells (MSCs), which hold immense potential in repairing injured tissues and organs, as well as treating various diseases.

    Epithelial stem cells (EpSCs) form the soft tissues that connect, support or surround other structures and organs of the body including cornea and skin, as well as lining of the stomach and liver. Based on current research, EpSCs are considered to be a possible key resource for epidermal and skin regeneration as they have been used to treat surface ulcers, burns and tissue trauma such as those from accidents. They are also being studied in regenerative medicine for corneal replacement.

    Mesenchymal stem cells (MSCs), meanwhile, are the building blocks of the structural tissues of the human body such as bone, cartilage, muscle, fibrous tissues and fat. More than 280 clinical trials* are on-going worldwide to uncover the potential applications of MSCs, including tissue repair in heart failure, cartilage injury, stroke, spinal cord injury, amyotropic lateral sclerosis, Parkinson’s disease and multiple sclerosis, as well as supporting hematopoietic stem cell (HSC) transplantation** by reducing immune system complications and shortening time to engraftment.

    Both EpSCs and MSCs are abundant in the umbilical cord, whereas cord blood is a proven source of hematopoietic (HSCs) or blood-forming stem cells used in the treatment of certain cancers, blood disorders and immune-deficiencies. MSCs can also be found in cord blood, though in much smaller quantities.


      1  of  2  NEXT

    Recommended Videos
  • You're almost there! Check your inbox.

    We sent a verification email. Can't find it? Check your spam, junk, and promotions folder.
View More Stories About
Trending in Summit Network
View more articles